⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24079402 | 0.81 | — | — | |
| SCHEMBL801270 | 0.74 | — | — | |
| SCHEMBL21966138 | 0.74 | ALDH1A1 (0.37) | — | |
| SCHEMBL1615790 | 0.72 | — | — | |
| SCHEMBL3907850 | 0.72 | — | — | |
| SCHEMBL1615800 | 0.72 | CHRNB2 (0.58) | — | |
| SCHEMBL19910614 | 0.72 | — | — | |
| SCHEMBL3096327 | 0.72 | ALDH1A1 (0.39) | — | |
| SCHEMBL3909951 | 0.72 | — | — | |
| SCHEMBL2195181 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9850491-B2 | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2017-12-26 | — | — | US | disclosed |
| US-20170029824-A1 | RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | BANK OF AMERICA, N.A. | 2017-02-02 | — | — | US | disclosed |